
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Tiotropium Related Compound H ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C9H16BrNO2Color and Shape:White PowderMolecular weight:250.14Ceftazidime δ-3-Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H22N6O7S2Color and Shape:Yellow Off-White Crystalline PowderMolecular weight:546.58Lansoprazole Related Compound A (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H14F3N3O3SColor and Shape:White Crystalline PowderMolecular weight:385.36Clarithromycin Impurity Q (Clarithromycin N-oxide)
CAS:Lactones nesoiFormula:C38H69NO14Color and Shape:White PowderMolecular weight:763.95 g/molAprepitant Related Compound B (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H21F7N4O3Color and Shape:White Off-White Crystalline PowderMolecular weight:534.15019P-Chloroaniline
CAS:Aniline derivatives and their saltsFormula:C6H6ClNColor and Shape:White Light Yellow PowderMolecular weight:127.57Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C19H22N2O5Color and Shape:White PowderMolecular weight:358.15287Chloropropyl Vanillin (4-(3-Chloropropoxy)-3-methoxybenzaldehyde)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of products of heading 2912Formula:C11H13ClO3Color and Shape:PowderMolecular weight:228.05532Orphenadrine Related Compound B (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride)
CAS:Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormula:C20H28ClNOColor and Shape:White Off-White PowderMolecular weight:333.18594Oxazepam Related Compound C (6-chloro-4-phenylquinazoline-2-carbaldehyde)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen heteroFormula:C15H9ClN2OColor and Shape:Yellow Orange PowderMolecular weight:268.7Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS:Sulfonamides, nesoiFormula:C23H31N7O7SColor and Shape:White PowderMolecular weight:549.20057Pravastatin 1,1,3,3-Tetramethylbutylamine
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormula:C23H36O7·C8H19NColor and Shape:White Crystalline Powder CrystalsMolecular weight:424.2461Sulindac Related Compound A ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C20H17FO3SColor and Shape:Yellow PowderMolecular weight:356.41Benazepril Related Compound D (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
CAS:Lactams, nesoiFormula:C24H34N2O5·HClColor and Shape:White Fine PowderMolecular weight:430.24677Ecamsule Related Compound A (1,4-Phenylenedimethanol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C8H10O2Color and Shape:White Crystalline PowderMolecular weight:138.06808Fosinopril Related Compound H (4-phenylbutyl phosphonic acid)
CAS:Organo-inorganic compounds, nesoiFormula:C10H15O3PColor and Shape:White PowderMolecular weight:214.07588Ketorolac Related Compound C (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H11NO2Color and Shape:Yellow SolidMolecular weight:225.24Buspirone Related Compound A (2-(Piperazin-1-yl)pyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C8H12N4Color and Shape:Clear Light Yellow LiquidMolecular weight:164.21Orphenadrine Related Compound F (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C18H23NO·C6H8O7Color and Shape:White PowderMolecular weight:461.20497Mefloquine Related Compound A (threo-mefloquine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H16F6N2O·HClColor and Shape:White PowderMolecular weight:378.11668

